Результаты поиска - Brahmer, Julie
- Отображение 1 - 20 результаты of 103
- Перейти на следующую страницу
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4... по Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.
Опубликовано 2010Текст -
12
Prognostic Models to Predict Survival in Non-Small Cell Lung Cancer Patients Treated with First-Line Paclitaxel and Carboplatin with or without Bevacizumab по Hoang, Tien, Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.
Опубликовано 2012Текст -
13
Genetic and Proteomic Features Associated with Survival after Treatment with Erlotinib in First-Line Therapy of Non-small Cell Lung Cancer in Eastern Cooperative Oncology Group 350... по Amann, Joseph M., Lee, Ju-Whei, Roder, Heinrich, Brahmer, Julie, Gonzalez, Adriana, Schiller, Joan H., Carbone, David P.
Опубликовано 2010Текст -
14
Sex Differences in Outcome with Bevacizumab Therapy: Analysis of Patients with Advanced-Stage Non-Small-Cell Lung Cancer Treated with or without Bevacizumab in Combination with Pac... по Brahmer, Julie R., Dahlberg, Suzanne E., Gray, Robert J., Schiller, Joan H., Perry, Michael C., Sandler, Alan, Johnson, David H.
Опубликовано 2011Текст -
15
Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non–Small-Cell Lung Cancer T... по Sandler, Alan B., Schiller, Joan H., Gray, Robert, Dimery, Isaiah, Brahmer, Julie, Samant, Meghna, Wang, Lisa I., Johnson, David H.
Опубликовано 2009Текст -
16
Body Mass Index and its Association with Clinical Outcomes for Advanced Non-Small Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials по Dahlberg, Suzanne E., Schiller, Joan H., Bonomi, Philip B., Sandler, Alan B., Brahmer, Julie R., Ramalingam, Suresh S., Johnson, David H.
Опубликовано 2013Текст -
17
Development of MEDI4736, an anti-programmed cell death ligand 1 (PD-L1) antibody, as monotherapy or in combination with other therapies in the treatment of non-small cell lung canc... по Brahmer, Julie, Balmanoukian, Ani, Goldberg, Sarah, Ou, Sai-Hong, Blake-Haskins, Andrew, Karakunnel, Joyson, Stockman, Paul, Rizvi, Naiyer, Antonia, Scott
Опубликовано 2014Текст -
18
Pleural fluid secondary to pulmonary cryptococcal infection: a case report and review of the literature по Zhang, Yuan, Zhang, Sean X., Trivedi, Julie, Toll, Adam D., Brahmer, Julie, Hales, Russell, Bonerigo, Sarah, Zeng, Mingying, Li, Huiping, Yung, Rex C.
Опубликовано 2019Текст -
19
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors по Messersmith, Wells A., Jimeno, Antonio, Ettinger, David, Laheru, Dan, Brahmer, Julie, Lansey, Dina, Khan, Yasmin, Donehower, Ross C., Elsayed, Yusri, Zannikos, Peter, Hidalgo, Manuel
Опубликовано 2008Текст -
20
Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen по Cappelli, Laura C., Brahmer, Julie R., Forde, Patrick M., Le, Dung T., Lipson, Evan J., Naidoo, Jarushka, Zheng, Lei, Bingham, Clifton O., Shah, Ami A.
Опубликовано 2018Текст